Malik Fady Ibraham bought CYTK
March 15, 2026 · Form 4 insider transaction
Malik Fady Ibraham bought 1,665 shares of Cytokinetics, Incorporated at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,665
Price
$0.00
Total value
N/A
InsiderMalik Fady Ibraham
Role—
SecurityIncentive Stock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateMarch 15, 2026
Filing dateMarch 17, 2026
Shares owned after1,665
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Annual equity award comprised of stock options that vest in 48 equal monthly installments, subject to officer's continued employment with the company on each vesting date. Stock options are subject to the company's Amended and Restated 2004 Equity Incentive Plan.